Bausch Health Companies Inc BHC

TSX CA Healthcare Pharmaceuticals

$6.89 ▲ +14.26% (+$0.86)

Index member: S&P/TSX Composite

⬆️ Above Yest. High

Open $6.00

Prev Close $6.03

Day Range $5.98 – $6.92

52W Range $6.10 – $11.97

Market Cap $2.35B

P/E (TTM) 14.30

Beta 1.28

EPS (TTM) $-3.24

📋 Company Profile

Industry	Pharmaceuticals
Sector	Healthcare
Country	CA
Exchange	TORONTO STOCK EXCHANGE
Currency	USD
IPO Date	1994-09-20
Shares Out.	373,480,000
Website	bauschhealth.com/ ↗
Phone	18003611448
Employees	20,300
Revenue	$2.52B
Gross Profit	$1.79B
Net Income	-$1.43B
Free Cash Flow	$1.03B
Total Assets	$24.50B
Total Liabilities	$25.58B
Equity	-$1.08B

About Bausch Health Companies Inc

Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.

Bausch Health Companies Inc is a publicly traded company under the ticker symbol BHC on the TORONTO STOCK EXCHANGE, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.